|
Author Question: An insurance company that sells or administers an insurance contract is also known as the carrier ... (Read 80 times) |
Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.
Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.
More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.
The average human gut is home to perhaps 500 to 1,000 different species of bacteria.
For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.